港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

71.400

+0.1500.21%

成交量：364.43萬

成交額：2.60億

市值：739.70億

市盈率：31.69

高：73.350

開：70.100

低：68.850

收：71.250

資料載入中...

總覽公司新聞公告

與薇婭深度綁定，鉅子生物財報亮眼難掩“拿證”無進展

【大行評級｜花旗：上調鉅子生物目標價至78.1港元維持“買入”評級】花旗發表研報指，鉅子生物2024財年淨利潤增長42%，符合預期；收入增長57%，超出預期，抵銷了較高的銷售與分銷費用。該行提及，鉅子生物管理層目標於2025財年實現收入增長25%至28%，淨利潤目標增長21%至24%。此外，管理層對今年首季表現感到滿意，特別是婦女節促銷，令管理層對實現全年目標有信心。該行將鉅子生物目標價由68.2港元上調至78.1港元，維持“買入”評級。

鉅子生物(2367.HK)2024年年報點評：大單品驅動收入利潤高增新品佈局穩步推進

鉅子生物去年業績暴增，但八成多依賴可復美，研發佔比下滑

南方都市报

花旗：鉅子生物去年淨利潤增長符預期升目標價至78.1港元

花旗：鉅子生物(02367)去年淨利潤增長符預期升目標價至78.1港元

《大行》花旗：鉅子生物(02367.HK)去年淨利潤增長符預期升目標價至78.1元

阿斯达克财经

高盛：升鉅子生物目標價至72港元重申“買入”評級

高盛：升鉅子生物(02367)目標價至72港元重申“買入”評級

異動解讀 | 鉅子生物盤中大跌6.03%，南向資金連續減持或為主因

鉅子生物(02367)2024年淨利同比增長42.1% 擬派末期股息及特別股息合計1.1942元人民幣

鉅子生物(02367)發佈年度業績股東應占溢利20.62億元同比增加42.1% 持續加大研發投入

鉅子生物03月26日獲主力加倉24萬元

鉅子生物03月21日主力淨流出628萬元散戶資金買入

國聯民生證券：社服順週期回升趨勢顯現 IP+、AI+創造新機遇

一週IPO觀察：鉅子生物上市大漲，子不語、多想雲招股，蝸牛遊戲赴美上市

财经自媒体

鉅子生物03月13日主力淨流出300萬元散戶資金買入

鉅子生物盤中異動快速下跌5.01%

鉅子生物(02367)股價下跌5.007%，現價港幣$68.3

阿斯达克财经

【券商聚焦】招銀國際指2月美妝銷售數據顯示國貨品牌於抖音平臺重點發力護膚品類增長強勁

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":71.4,"timestamp":1743667696030,"preClose":71.25,"halted":0,"volume":3644322,"delay":0,"floatShares":1036000000,"shares":1036000000,"eps":2.2532308241048176,"marketStatus":"清明節休市","change":0.15,"latestTime":"04-03 16:08:16","open":70.1,"high":73.35,"low":68.85,"amount":260403832,"amplitude":0.063158,"askPrice":71.5,"askSize":7600,"bidPrice":71.4,"bidSize":28400,"shortable":3,"etf":0,"ttmEps":2.2099437971618525,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":71.25,"dividendRate":0.013585,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.6335034764670934,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1036000000,"roa":"21.88%","roe":"35.88%","lyrEps":2.253231,"volumeRatio":0.6335034764670934,"shares":1036000000,"dividePrice":0.97,"high":73.35,"amplitude":0.063158,"preClose":71.25,"low":68.85,"week52Low":35,"pbRate":"9.70","psRate":"12.45","week52High":75.2,"institutionHeld":0,"latestPrice":71.4,"committee":0.577778,"eps":2.2532308241048176,"divideRate":0.013585,"volume":3644322,"delay":0,"ttmEps":2.2099437971618525,"open":70.1,"prevYearClose":49.9,"prevWeekClose":68,"prevMonthClose":70.45,"prevQuarterClose":70.45,"fiveDayClose":67.45,"twentyDayClose":70.35,"sixtyDayClose":46.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522594830","title":"與薇婭深度綁定，鉅子生物財報亮眼難掩“拿證”無進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2522594830","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522594830?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 12:49","pubTimestamp":1743137340,"startTime":"0","endTime":"0","summary":"截至2024年末，巨子生物现金及现金等价物增至40.30亿元，较2023年25.04亿元同比增长61%，彰显财务稳健。巨子生物对此亦心知肚明。原料成本与竞品冲击，医美“拿证”无进展重组胶原蛋白是巨子生物的核心竞争力，但原料成本下降正动摇其高定价优势。巨子生物“进军医美”的口号已喊了数年，宣称储备四款Ⅲ类重组胶原针剂，两款预计2024年二季度获批，但至今无进展。巨子生物暂未回应降价计划，其技术领先优势恐被稀释。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032812503897261791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032812503897261791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367"],"gpt_icon":0},{"id":"2522564940","title":"【大行評級｜花旗：上調鉅子生物目標價至78.1港元 維持“買入”評級】花旗發表研報指，鉅子生物2024財年淨利潤增長42%，符合預期；收入增長57%，超出預期，抵銷了較高的銷售與分銷費用。該行提及，鉅子生物管理層目標於2025財年實現收入增長25%至28%，淨利潤目標增長21%至24%。此外，管理層對今年首季表現感到滿意，特別是婦女節促銷，令管理層對實現全年目標有信心。該行將鉅子生物目標價由68.2港元上調至78.1港元，維持“買入”評級。","url":"https://stock-news.laohu8.com/highlight/detail?id=2522564940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522564940?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 10:27","pubTimestamp":1743128829,"startTime":"0","endTime":"0","summary":"花旗发表研报指，巨子生物2024财年净利润增长42%，符合预期；收入增长57%，超出预期，抵销了较高的销售与分销费用。该行提及，巨子生物管理层目标于2025财年实现收入增长25%至28%，净利润目标增长21%至24%。此外，管理层对今年首季表现感到满意，特别是妇女节促销，令管理层对实现全年目标有信心。该行将巨子生物目标价由68.2港元上调至78.1港元，维持“买入”评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/28102749103829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02367"],"gpt_icon":0},{"id":"2522549391","title":"鉅子生物(2367.HK)2024年年報點評：大單品驅動收入利潤高增 新品佈局穩步推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2522549391","media":"国元证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522549391?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 00:00","pubTimestamp":1743091200,"startTime":"0","endTime":"0","summary":"事件：公司发布2024 年年度报告。可复美胶原棒势能延续，焦点系列有望快速放量，新品布局稳步推进分品牌来看，24 年可复美实现收入45.4 亿元，同比增长62.9%。明星产品胶原棒势能延续，健康的用户拉新和复购驱动增长，24年天猫+抖音双渠道GMV 近24 亿。新品焦点系列聚焦皮肤亚状态人群，定位差异化，核心单品焦点面霜上新9 个月实现天猫+抖音2.77 亿GMV。公司持续加强线上多平台人群破圈与场景运营，24 年可复美抖音GMV18 亿元，同比翻番增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328163636a6a72ca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328163636a6a72ca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2522830913","title":"鉅子生物去年業績暴增，但八成多依賴可復美，研發佔比下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2522830913","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522830913?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 21:12","pubTimestamp":1743081131,"startTime":"0","endTime":"0","summary":"3月27日，巨子生物发布2024年业绩公告。不过，巨子生物对可复美这一单一品牌的依赖度进一步上升，后者贡献了八成以上的收入。招引国际分析巨子生物业绩的研报中提到，2024年，可复美和可丽金在猫淘、京东、抖音的GMV共计达54亿元，同比增长57%。另外，在大部分国货美妆都在提高研发比例的当下，巨子生物2024年的研发成本占总收入的占比竟然在下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327213652a4440b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327213652a4440b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2522634042","title":"花旗：鉅子生物去年淨利潤增長符預期 升目標價至78.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522634042","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522634042?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 17:23","pubTimestamp":1743067380,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　花旗发布研报称，巨子生物（02367）2024财年净利润增长42%，符合预期；收入增长57%，超出预期，抵销了较高的销售与分销费用。该行将巨子生物目标价由68.2港元上调至78.1港元，维持“买入”评级。\n　　该行提及，巨子生物管理层目标于2025财年实现收入增长25%至28%，略低于预期的30%；净利润目标增长21%至24%，略低于预期的25%。此外，管理层对今年首季表现感到满意，特别是妇女节促销，令管理层对实现全年目标有信心。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-27/doc-inerauep8063604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2522834471","title":"花旗：鉅子生物(02367)去年淨利潤增長符預期 升目標價至78.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522834471","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522834471?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 16:46","pubTimestamp":1743065171,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，巨子生物(02367)2024财年净利润增长42%，符合预期;收入增长57%，超出预期，抵销了较高的销售与分销费用。该行将巨子生物目标价由68.2港元上调至78.1港元，维持“买入”评级。该行提及，巨子生物管理层目标于2025财年实现收入增长25%至28%，略低于预期的30%;净利润目标增长21%至24%，略低于预期的25%。此外，管理层对今年首季表现感到满意，特别是妇女节促销，令管理层对实现全年目标有信心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2522234958","title":"《大行》花旗：鉅子生物(02367.HK)去年淨利潤增長符預期 升目標價至78.1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522234958","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522234958?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 16:10","pubTimestamp":1743063000,"startTime":"0","endTime":"0","summary":"花旗发表研报指，巨子生物(02367.HK) 2024财年净利润增长42%，符合预期；收入增长57%，超出预期，抵销了较高的销售与分销费用。该行提及，巨子生物管理层目标于2025财年实现收入增长25%至28%，略低于预期的30%；净利润目标增长21%至24%，略低于预期的25%。此外，管理层对今年首季表现感到满意，特别是妇女节促销，令管理层对实现全年目标有信心。该行将巨子生物目标价由68.2元上调至78.1元，维持“买入”评级。(js/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-27 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170600934_s.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1428854/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2522701310","title":"高盛：升鉅子生物目標價至72港元 重申“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2522701310","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522701310?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 15:27","pubTimestamp":1743060420,"startTime":"0","endTime":"0","summary":"　　高盛发布研报称，巨子生物去年下半年业务继续超出预期，将其2025至2027财年净利润预测微调不足1%，目前料今年销售及净利润同比增长28%与24%，至71亿及25.5亿元人民币。该行对其目标价由64港元上调至72港元，重申“买入”评级。　　报告显示，公司销售及净利润各同比增长56%与38%，超过该行预期8%与2%，并较市场预期高9%及5%。该行认为公司派息率达60%带来正面惊喜，意味着股息率达2%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-27/doc-inerapwk5143710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2522314169","title":"高盛：升鉅子生物(02367)目標價至72港元 重申“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2522314169","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522314169?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:29","pubTimestamp":1743056998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，巨子生物(02367)去年下半年业务继续超出预期，将其2025至2027财年净利润预测微调不足1%，目前料今年销售及净利润同比增长28%与24%，至71亿及25.5亿元人民币。该行对其目标价由64港元上调至72港元，重申“买入”评级。报告显示，公司销售及净利润各同比增长56%与38%，超过该行预期8%与2%，并较市场预期高9%及5%。去年收入与净利润分别同比升57%及42%，亦均超出管理层的最新指引，分别高出该行预测4%和1%，及较市场预期高5%与3%。该行认为公司派息率达60%带来正面惊喜，意味着股息率达2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"1150492940","title":"異動解讀 | 鉅子生物盤中大跌6.03%，南向資金連續減持或為主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1150492940","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150492940?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 09:52","pubTimestamp":1743040369,"startTime":"0","endTime":"0","summary":"港股上市公司巨子生物今日盘中大跌6.03%，引发市场关注。此次股价下跌可能与近期南向资金持续减持有关。截至3月26日收盘，港股通共持有巨子生物14376.19万股，占流通股的13.88%。数据显示，该股近5个交易日下跌3.34%，港股通累计减持171.64万股；而在近20个交易日内，该股上涨8.54%，但港股通累计减持高达857.95万股。投资者应密切关注该公司后续发展及资金流向变化，谨慎评估投资风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 巨子生物盘中大跌6.03%，南向资金连续减持或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0},{"id":"2522980707","title":"鉅子生物(02367)2024年淨利同比增長42.1% 擬派末期股息及特別股息合計1.1942元人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2522980707","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522980707?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 22:10","pubTimestamp":1742998212,"startTime":"0","endTime":"0","summary":"金吾财讯 | 巨子生物 发布截至2024年12月31日止年度业绩公告，报告期内实现收入55.39亿元人民币，同比增长57.2%；归母净利润20.62亿元，同比增长42.1%。每股基本盈利2.10元，去年同期为1.49元。拟派末期股息每股0.6021元，及特别股息0.5921元，合计1.1942元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/M2UyZGNiNDRjZmIyOTFjZmIzN2JhMmQ2MDYyMzM5MDkyOTMyMQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/M2UyZGNiNDRjZmIyOTFjZmIzN2JhMmQ2MDYyMzM5MDkyOTMyMQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955997","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2522125805","title":"鉅子生物(02367)發佈年度業績 股東應占溢利20.62億元 同比增加42.1% 持續加大研發投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2522125805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522125805?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 21:04","pubTimestamp":1742994278,"startTime":"0","endTime":"0","summary":"智通财经APP讯，巨子生物 发布截至2024年12月31日止年度业绩，该集团期内取得收入55.39亿元，同比增加57.2%;归属于母公司持有者盈利20.62亿元，同比增加42.1%;每股基本盈利2.1元;拟派发末期股息每股0.6021元及特别股息每股0.5921元。报告期内，公司研发支出达到人民币1.07亿元，同比增长42.1%，研发支出占收入比例1.9%。截至报告期末，集团拥有188项在研项目。截至报告期末，公司已获授权及申请中专利达到167项，其中报告期内新增74项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":1},{"id":"2522446478","title":"鉅子生物03月26日獲主力加倉24萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522446478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522446478?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 16:15","pubTimestamp":1742976959,"startTime":"0","endTime":"0","summary":"03月26日, 巨子生物股价涨3.03%，报收68.00元，成交金额2.27亿元，换手率0.33%，振幅4.77%，量比1.03。巨子生物今日主力资金净流入24万元，上一交易日主力净流入1018万元。该股近5个交易日下跌2.77%，主力资金累计净流入395万元；近20日主力资金累计净流入1.52亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326165545a6a479c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250326165545a6a479c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2521470291","title":"鉅子生物03月21日主力淨流出628萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2521470291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521470291?lang=zh_tw&edition=fundamental","pubTime":"2025-03-21 16:17","pubTimestamp":1742545038,"startTime":"0","endTime":"0","summary":"03月21日, 巨子生物股价跌0.85%，报收69.60元，成交金额2.25亿元，换手率0.31%，振幅5.63%，量比0.77。巨子生物今日主力资金净流出628万元，上一交易日主力净流入346万元。该股近5个交易日上涨1.91%，主力资金累计净流入601万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入1.55亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170852a43c7444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250321170852a43c7444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2520438022","title":"國聯民生證券：社服順週期回升趨勢顯現 IP+、AI+創造新機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2520438022","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520438022?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 16:50","pubTimestamp":1742460631,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国联民生证券发布研报称，近日，中共中央办公厅、国务院办公厅印发《提振消费专项行动方案》，方案部署了相关提振消费的8方面30项重点任务。国联民生证券主要观点如下：近期顺周期跟踪：回升趋势显现2025年以来同比数据有比较明显的改善：1)人服：新增招聘贴数2025年3月以来每周均有明显的改善。风险提示消费复苏不及预期风险，市场竞争加剧超风险，AI应用效果不及预期风险，海外复盘研究存在局限性风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1264730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","LU1481599808.USD","02367","BK1207","LU1487256676.USD","IP","09896","BK4136","BK1249","01318","BK4588","LU2488822045.USD","06181","601456","BK4585","LU1481600234.SGD","BK1227","BK0276","162414","LU2463526074.USD","BK1246"],"gpt_icon":1},{"id":"2519878125","title":"一週IPO觀察：鉅子生物上市大漲，子不語、多想雲招股，蝸牛遊戲赴美上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2519878125","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519878125?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 17:18","pubTimestamp":1741943880,"startTime":"0","endTime":"0","summary":"港股IPO观察截止2022年的第45周，港交所1家新股上市，4家招股，6家递交上市申请。截至2022年7月15日，今年港交所新上市60家，共募资856.58亿港元。公司引入3名基石投资者，合共认购认购2260万美元的发售股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-14/doc-inepritp9633129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367","BK4085","BK1114","BK1137","06696","BK1142","BK1207","LU2488822045.USD","SNAL","02420"],"gpt_icon":0},{"id":"2519811178","title":"鉅子生物03月13日主力淨流出300萬元 散戶資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2519811178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519811178?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 16:45","pubTimestamp":1741855502,"startTime":"0","endTime":"0","summary":"03月13日, 巨子生物股价跌3.13%，报收69.65元，成交金额4.40亿元，换手率0.61%，振幅5.29%，量比1.21。巨子生物今日主力资金净流出300万元，上一交易日主力净流入641万元。该股近5个交易日下跌2.27%，主力资金累计净流入5141万元；近20日主力资金累计净流入1.66亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313181424a1dafc41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313181424a1dafc41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1207","02367"],"gpt_icon":0},{"id":"2519005402","title":"鉅子生物盤中異動 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519005402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519005402?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 14:24","pubTimestamp":1741847061,"startTime":"0","endTime":"0","summary":"2025年03月13日下午盘14时24分，巨子生物股票出现波动，股价快速下跌5.01%。截至发稿，该股报68.300港元/股，成交量400.186万股，换手率0.39%，振幅5.08%。巨子生物股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，思路迪医药股份、永泰生物-B、康宁杰瑞制药-B涨幅较大，振幅较大的相关个股有迈博药业-B、荃信生物-B、创胜集团-B，振幅分别为50.91%、37.21%、17.86%。榜单显示，巨子生物旗下可复美冲进榜单TOP4，同比去年，可复美排名提升9名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313142422ab637001&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250313142422ab637001&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2519008118","title":"鉅子生物(02367)股價下跌5.007%，現價港幣$68.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2519008118","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519008118?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 14:24","pubTimestamp":1741847040,"startTime":"0","endTime":"0","summary":"[下跌股]巨子生物(02367) 股价在下午02:24比前收市价下跌5.007%，现股价为港币$68.3。至目前为止，今日最高价为$71.95，而最低价为$68.3。总成交量为400.186万股，总成交金额为港币$2.803亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2503133215/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367","BK1207","LU2488822045.USD"],"gpt_icon":0},{"id":"2519072118","title":"【券商聚焦】招銀國際指2月美妝銷售數據顯示國貨品牌於抖音平臺重點發力 護膚品類增長強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2519072118","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519072118?lang=zh_tw&edition=fundamental","pubTime":"2025-03-13 13:40","pubTimestamp":1741844452,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，2月美妆销售数据显示国货品牌于抖音平台重点发力，尤其护肤品类增长强劲。38大促中，毛戈平表现亮眼，成功斩获抖音彩妆榜首。2M25累计GMV同比增长10%。其中同比表现出色的有巨子生物、丸美、上海家化、毛戈平；与2024年季度同比增幅相比，丸美、上海家化增速提升显著。该行指，截至3月11日，该行重点关注的美妆股涨幅约47%，其中毛戈平涨88%，巨子生物涨67%，上美股份涨45%，上海家化涨14%，丸美涨8%。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01318","02367","02145","BK1207","LU2488822045.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1743177600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-04-03","current":32.960917,"percent":0.76819,"low":18.546195,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"high":60.214956,"avg":30.40921,"sd":6.612573,"marketCap":72606945600},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600}],"updateTime":1743726150393}}}